Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Lags Revenue Estimates

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.48 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.02%. A quarter ago, it was expected that this company would post a loss of $0.85 per share when it actually produced a loss of $0.76, delivering a surprise of 10.59%.Over the last four quarters, the company has s ...